A detailed history of Capstone Investment Advisors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 10,734 shares of MNKD stock, worth $54,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,734
Holding current value
$54,314
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$3.42 - $5.74 $36,710 - $61,613
10,734 New
10,734 $57,000
Q4 2023

Feb 12, 2024

BUY
$3.34 - $4.29 $217,527 - $279,399
65,128 New
65,128 $237,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.3B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.